February 16, 2024 · Form 4 insider transaction
North Michael Paul bought 8,277 shares of Amedisys, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
The Issuer awarded the Reporting Person 8,277 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.; The number of shares in Column 5 reflects the addition of an aggregate of 11,250 shares of common stock issued to the Reporting Person upon the exercise of stock options on July 18, 2019 and July 24, 2019 that the Issuer discovered were incorrectly reported solely as open market sales without corresponding stock option exercises (rather than a cashless exercise of the stock options). The number of shares reported in this column reflects the Reporting Person's current total Table I holdings.; The total amount of shares beneficially owned includes 1,633 shares held in an employee stock purchase plan account.